Zynex Inc
NASDAQ:ZYXI
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.19
13.74
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Zynex Inc
Zynex Inc
Accounts Payable
Zynex Inc
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zynex Inc
NASDAQ:ZYXI
|
Accounts Payable
$9.3m
|
CAGR 3-Years
51%
|
CAGR 5-Years
37%
|
CAGR 10-Years
13%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Payable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Payable
$907m
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
Stryker Corp
NYSE:SYK
|
Accounts Payable
$1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
15%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Payable
$4.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Payable
$218.7m
|
CAGR 3-Years
22%
|
CAGR 5-Years
11%
|
CAGR 10-Years
15%
|
|
Zynex Inc
Glance View
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 774 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on drugs and medications and provide rehabilitation and through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current (IFC), neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation (TENS). The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, and E-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream, Knee Braces and LSO Back Braces, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter. CM-1500 is a Zynex fluid monitoring system.
See Also
What is Zynex Inc's Accounts Payable?
Accounts Payable
9.3m
USD
Based on the financial report for Sep 30, 2024, Zynex Inc's Accounts Payable amounts to 9.3m USD.
What is Zynex Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
13%
Over the last year, the Accounts Payable growth was 15%. The average annual Accounts Payable growth rates for Zynex Inc have been 51% over the past three years , 37% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
